Zura Bio is company a clinical-stage biotechnology company advancing immunology assets into development programs. It aims to develop a portfolio of therapeutic indications for ZB-168 which build on existing data in Type 1 Diabetes demonstrating a favorable safety profile and strong biological rationale.